Receptivity to new smokeless tobacco products among test market populations

测试市场人群对新型无烟烟草产品的接受度

• 批准号: 8092734
• 负责人: Lois Barbara Biener
• 金额: $ 59.55万
• 依托单位: UNIVERSITY OF MASSACHUSETTS BOSTON
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8092734
• 关键词: Adopted; Adoption; Adult; Advertising; Area; Awareness; Behavior; Benchmarking; Camels; Cellular Phone; Cigarette; Cigarette Smoker; Cities; Consumption; Cross-Sectional Studies; Data; Disease; Environment; Environmental Tobacco Smoke; Exposure to; Female; Future; Health; Home environment; Household; Intention; Internet; Knowledge; Label; Mails; Manufacturer Name; Marketing; Measures; Modeling; Modification; Motivation; NIH Program Announcements; National Cancer Institute; National Institute of Drug Abuse; Nature; Nicotine; Nitrosamines; Pattern; Peer Group; Perception; Population; Population Surveillance; Prevalence; Product Packaging; Public Health; Recording of previous events; Regulation; Relative (related person); Reporting; Research; Respondent; Sales; Sampling; Sensory; Sentinel; Smoke; Smokeless; Smokeless Tobacco; Smoker; Smoking; Surveys; System; Taste Perception; Telephone; Testing; Time; Tobacco; Tobacco Dependence; Tobacco use; United States; Withdrawal; Woman; behavior change; cigarette smoking; cost; design; disorder risk; heuristics; improved; innovation; interest; male; non-smoker; population based; population survey; public health relevance; response; smoking cessation; snus; social group; tobacco exposure

DESCRIPTION (provided by applicant): In the context of declining sales of cigarettes, the marketing and sale of smokeless tobacco is on the rise in the United States. Currently four major U.S. cigarette manufacturers have introduced new spitless, smokeless tobacco products modeled on Swedish snus and targeted specifically to cigarette smokers. There is considerable controversy about the appropriate public health approach to these new, relatively low nitrosamine, smokeless tobacco products. Nevertheless the growing availability of these products is a fact, and to date there is virtually no population-based data on the use of these products. The National Cancer Institute and the National Institute of Drug Abuse have issued a Program announcement seeking research to improve knowledge about the use of potential reduced exposure tobacco products, including developing surveillance systems and assessing behavior changes that may accompany their use such as dual use of cigarettes and smokeless products. This application is directed to those purposes. At this time, Indianapolis and Dallas/Ft. Worth are the only areas where the two major brands, Camel Snus and Marlboro Snus, are both available. By means of an efficient, dual-frame sampling approach, this study will carry out a population-based telephone survey of 4540 adults in those test markets designed to provide evidence of the nature of consumer receptivity to the new snus products, the rate at which smokers and nonsmokers are trying the product and either rejecting it or adopting it for regular use, and the likely impact of regular use on smoking patterns. In addition, the project will contribute to refinement of surveillance measures and will establish benchmarks for awareness, trial and regular use of snus as well as perceptions of harmfulness against which future comparisons can be made as advertising messages, marketing strategies and/or product constituents change. By including a cell phone supplement, it will increase knowledge of how omission of cell phone only households may bias estimates of snus use, and build capacity to integrate cell phone samples into population surveys. Finally, if the rate of snus adoption is high enough to warrant continued study, this project will provide a panel of respondents who can be followed over time. PUBLIC HEALTH RELEVANCE: Low nitrosamine smokeless tobacco products being marketed to cigarette smokers in the U.S. could potentially undermine motivation to quit smoking, and increase the prevalence of tobacco addiction and related disease. On the other hand, they could reduce cigarette consumption which would lower disease risk. This study provides an initial look at how the population of two cities is responding to the products.

描述（由申请人提供）：在卷烟销售下降的背景下，无烟烟草的营销和销售在美国呈上升趋势。目前，美国四家主要的卷烟制造商已经推出了以瑞典鼻烟为模型的新的无痰无烟烟草产品，专门针对吸烟者。对于这些新的、亚硝胺含量相对较低的无烟烟草产品的适当公共卫生方法存在相当大的争议。尽管如此，这些产品的供应日益增加是一个事实，迄今为止，几乎没有关于这些产品使用情况的人口数据。国家癌症研究所和国家药物滥用研究所发布了一项计划公告，寻求研究以提高对使用潜在的减少暴露烟草产品的知识，包括开发监测系统和评估可能伴随其使用的行为变化，例如香烟和无烟产品的双重使用。本申请针对这些目的。此时，印第安纳波利斯和达拉斯/英尺。沃思是唯一的两个主要品牌，骆驼鼻烟和万宝路鼻烟，都可用的地区。通过一种有效的双框架抽样方法，本研究将在这些测试市场中对4540名成年人进行一项基于人口的电话调查，旨在提供消费者对新鼻烟产品的接受程度的证据，吸烟者和非吸烟者尝试该产品并拒绝或采用该产品进行常规使用的比率，以及常规使用对吸烟模式的可能影响。此外，该项目将有助于完善监督措施，并将为提高对鼻烟的认识、试用和定期使用以及对危害的认识建立基准，随着广告信息、营销策略和/或产品成分的变化，今后可以对这些基准进行比较。通过包括手机补充，它将增加对只使用手机的家庭的遗漏如何可能使对鼻烟使用的估计产生偏差的了解，并建立将手机样本纳入人口调查的能力。最后，如果鼻烟采用率高到足以保证继续研究，本项目将提供一组可以随时间推移进行跟踪的受访者。 公共卫生关系：在美国，向吸烟者销售的低亚硝胺无烟烟草产品可能会破坏戒烟的动机，并增加烟草成瘾和相关疾病的患病率。另一方面，他们可以减少吸烟，从而降低疾病风险。这项研究初步探讨了两个城市的人口对产品的反应。